Discover Great Companies Discover Great Clients
Popularity  6897   |   Followers  3   |   Likes  4   |   Feedback  3 Claim this company
Suzhou Industrial Park Jiangsu No.18 Yi Chuan Xue No.29 Ji Yin Zhi Liao No.62 Sheng Ming Ke Xue Yan Jiu Sheng Wu Ke Ji / Biotechnology Engineering Lin Chuang Yi Xue Pharmaceutical Industrial Ji Yin Bian Ji 科技型中小企业 独角兽企业 省民营科技企业 省科技型中小企业

Company Overview

  • Nature: Private Enterprise Size: 50-99 employees Founded: 10年
  • Industry: Pharmaceuticals/Bioengineering
  • Full name: Cure Genetics Co., Ltd.。

Development Stage

  • Stage: A轮, 1700万美元。
  • Honors: 科技型中小企业 独角兽企业 According to algorithm

About the Company

Cure Genetics Co., Ltd. was founded in July 2016. The company brings together scientists from * research institutions (Yale, MIT, Georgia Tech/Emory University, National University of Singapore) as well as expert advisors including academicians of the Chinese Academy of Sciences and national "*" talents. It is a precision medicine company with both * precision gene editing-delivery technology and clinical application translation capabilities, mainly dedicated to the research and development of novel therapeutic technologies and drugs for refractory tumors, complex human genetic diseases and other difficult diseases.
The company will fully leverage the cross-combination of multiple technological advantages, combined with gene sequencing and systems biology analysis methods, to achieve safe, efficient and targeted editing of single or multiple gene loci at the cellular, animal and human levels, break through the bottleneck of preclinical research, reduce clinical research risks, and deploy medical technology and new drug development to meet medical market demands; at the same time, the company will provide multi-level outsourcing services to research institutions and enterprises, comprehensively improving the level of life sciences, thereby accelerating the process of cooperation and independent industrialization, and striving to become a clinical application translation company of China's original gene editing technology.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Financing History (1 rounds)

Manage
A轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 1700万美元
  • Investor: 启明创投,清松资本,盛鼎投...

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 175.6148万(元)
Legal Representative: 徐元元
Date Established:
Credit Code: 91320594MA1MPQTY9C
Registered Address: 中国(江苏)自由贸易试验区苏州片区苏州工业园区桑田街218号生物医药产业园二期B区20号楼101、201单元

People who follow this company also follow

Competitors (Similar Companies)

“再造生命,重塑健康”
“Gene therapy drug development”
“To develop high-quality biologics that are accessible and affordable f”
生命科学 生物信息 生物制药 干细胞
生物科技/生物工程 生命科学 诊断试剂 试剂
生物科技/生物工程 医药 药物研发 生物医药
“Metabolomics research and application”
“Provider of intelligent production solutions for biopharmaceuticals”
医药 生物科技/生物工程 生物医药 细胞治疗
生物科技/生物工程 基因治疗 基因编辑 基因诊断
“端到端体内基因编辑技术与药物开发与生产商”
“新一代通用现货型细胞治疗药物研发商”
试剂 生物医药 基因治疗 细胞治疗
“Create more efficient, high-quality, and low-cost biologic macromolecu”

Discover Great Companies, Discover Great Clients

苏州公司名录 苏州“Industrial Park”公司名录 苏州“生物科技/生物工程”公司名录 苏州“临床医学”公司名录 苏州“遗传学”公司名录 苏州“生命科学研究”公司名录 苏州“基因治疗”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates